PMID: 15232468Jul 3, 2004Paper

Dry eye diagnosis and management in 2004

Current Opinion in Ophthalmology
Henry D Perry, Eric D Donnenfeld

Abstract

To document the changes in treatment paradigm for the management of dry eye. Restasis is 0.05% cyclosporine A and is the first immunomodulatory agent approved for treatment of dry eye. Mounting evidence supports the inflammatory mechanism as explanation for the occurrence of dry eye disease. Immunomodulation has been shown to be effective in treating patients with moderate to severe dry eye disease caused by keratoconjunctivitis sicca. This addresses one of the two main forms of dry eye. There is a new report that immunomodulation using topical 0.05% cyclosporine A (Restasis) may also have a positive effect on meibomian gland dysfunction, the other main form of dry eye. Dry eye disease is defined as an abnormality of tear film resulting in changes in the ocular surface. These changes may be seen on ocular examination with the use of fluorescein and supravital staining techniques. Classification of dry eye disease shows two main types: aqueous deficiency and evaporative loss. There is hope that both of these types of dry eye will respond to immunomodulation therapy. Restasis shows promise as the first of these agents to be approved as therapy to treat moderate to severe dry eye disease.

References

Apr 1, 1992·Ophthalmology·R P Feenstra, S C Tseng
Nov 1, 1984·Seminars in Arthritis and Rheumatism·R I FoxP Michelson
Oct 21, 1998·Experimental Eye Research·J E Jumblatt, M M Jumblatt
Nov 3, 1998·The British Journal of Ophthalmology·P Prabhasawat, S C Tseng
Dec 28, 1999·The British Journal of Ophthalmology·E M RochaD A Sullivan
Nov 7, 2002·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·David S SmallDiane D-S Tang-Liu
Jul 31, 2003·American Journal of Ophthalmology·Debra A SchaumbergM Reza Dana
Sep 26, 2003·Investigative Ophthalmology & Visual Science·Xiu Jun SongStephen C Pflugfelder
Dec 24, 2003·Investigative Ophthalmology & Visual Science·Yuichi HoriIlene K Gipson
Jan 1, 2004·American Journal of Ophthalmology·Cintia Sade De Paiva, Stephen C Pflugfelder

❮ Previous
Next ❯

Citations

Dec 20, 2005·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·C CursiefenF E Kruse
Dec 17, 2009·Zeitschrift für Rheumatologie·C Jacobi, C Cursiefen
Mar 23, 2013·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Shuya HaraJun Shimazaki
Feb 20, 2007·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Leonard Bielory
Apr 21, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Bruce I GaynesYevgeniva Sorokin
Aug 12, 2010·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Minjie ChenJia He
Jul 27, 2010·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·William F DavittAnna E Martin
Dec 12, 2012·International Ophthalmology Clinics·Michael Lawless, Christopher Hodge
Apr 17, 2007·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Holly Lorentz, Lyndon Jones
Jul 17, 2007·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Sruthi SrinivasanLyndon W Jones
Sep 8, 2011·Oman Journal of Ophthalmology·Ankita S BhavsarSunita M Jain
Jul 12, 2005·Current Medical Research and Opinion·Karl StonecipherDonna L Kerney
Apr 16, 2013·The Ocular Surface·Srihari NarayananAlison M McDermott
Oct 6, 2009·Optometry : Journal of the American Optometric Association·Erin McCabe, Srihari Narayanan
Feb 13, 2009·American Journal of Ophthalmology·Anita GuptaEsen Karamursel Akpek
Jan 23, 2010·Clinical & Experimental Ophthalmology·Ghasem FakhraieMarlene R Moster
Apr 20, 2010·Clinical & Experimental Ophthalmology·Gerard L Sutton, Peter Kim
Jun 22, 2013·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Gerard SuttonChristopher Hodge
Apr 26, 2005·International Journal of Pharmaceutics·F LallemandR Gurny
May 7, 2014·Veterinary Ophthalmology·Laura BarachettiBrian C Gilger
Oct 18, 2014·Seminars in Ophthalmology·Duna Raoof, Roberto Pineda
Apr 14, 2015·Journal of Avian Medicine and Surgery·Stephen P SmithNeil A Forbes
Jan 30, 2016·The British Journal of Ophthalmology·Morgane StraubCatherine Creuzot-Garcher
Apr 28, 2017·Ocular Immunology and Inflammation·Jay Siak, Soon-Phaik Chee
Jan 1, 2009·Expert Review of Clinical Pharmacology·Sophia K Mirza, Eve J Higginbotham
Oct 17, 2017·Advanced Healthcare Materials·Michelle L RataySteven R Little
Feb 26, 2016·The Cochrane Database of Systematic Reviews·Andrew D PuckerJason J Nichols
Mar 1, 2017·The Cochrane Database of Systematic Reviews·Qing PanEsen K Akpek
May 22, 2010·Ophthalmic Plastic and Reconstructive Surgery·Amy M Fowler, Jonathan J Dutton
Aug 6, 2009·Journal of Korean Medical Science·Ki Cheol ChangMyung Gyu Park
Nov 1, 2007·Ocular Immunology and Inflammation·Fatih OzcuraMehmet Rami Helvaci
Sep 16, 2017·Journal of Current Ophthalmology·Mohsen Bahmani KashkouliYasaman Hadi
Nov 25, 2020·Indian Journal of Ophthalmology·Bhavana SharmaRasik B Vajpayee
Jun 19, 2021·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Tsai-Chu YehChieh-Chih Tsai
Nov 30, 2006·The Ocular Surface·Lenio S Alvarenga, Mark J Mannis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Ophthalmology
Stephen C Pflugfelder
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
F LallemandR Gurny
The British Journal of Ophthalmology
S Tatlipinar, E K Akpek
© 2022 Meta ULC. All rights reserved